1.61
Coherus Oncology Inc (CHRS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
10.17%
12.75
|
11.57 | 10.25 | 7.599 | 54.14 |
| Cost Of Revenue |
8.71%
4.045
|
3.721 | 3.395 | 2.653 | 33.86 |
| Gross Profit |
10.87%
8.703
|
7.85 | 6.859 | 4.946 | 20.29 |
|
|
4.60%
54.58
|
52.18 | 52.34 | 50.38 | 62.53 |
| Interest Income/Expense |
3.27%
2.249
|
2.325 | 2.277 | 2.15 | 5.346 |
| Benefits Costs and Expenses |
5.36%
59.09
|
56.09 | 55.12 | 55.00 | 104.84 |
| Costs And Expenses |
4.87%
58.63
|
55.90 | 55.74 | 53.03 | 96.39 |
| Depreciation and Amortization |
7.25%
0.896
|
0.966 | 1.016 | 1.046 | 1.033 |
| Operating Income/Loss |
3.49%
-45.88
|
-44.33 | -45.49 | -45.44 | -42.25 |
| Income/Loss From Continuing Operations Before Tax |
4.11%
-46.35
|
-44.52 | -44.86 | -47.40 | -50.70 |
| Income/Loss From Continuing Operations After Tax |
4.11%
-46.35
|
-44.52 | -44.86 | -47.40 | -50.70 |
| Income/Loss From Discontinued Operations, Net Of Tax |
3.14%
8.704
|
8.986 | 342.63 | -9.171 | - |
|
|
5.94%
-37.64
|
-35.53 | 297.77 | -56.57 | -50.70 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.06%
1.0872
|
116.23 | 116.08 | 115.86 | 0.2903 |
| Diluted Average Shares |
99.06%
1.0872
|
116.23 | 116.08 | 115.86 | -11.73 |
| Basic Earnings Per Share |
9.68%
-0.34
|
-0.31 | 2.57 | -0.49 | -0.44 |
| Diluted Earnings Per Share |
9.68%
-0.34
|
-0.31 | 2.57 | -0.49 | -0.40 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):